Myosin Modulator Aficamten Inhibits Force by Altering Myosin’s Biochemical Activity Without Changing Thick Filament Structure

We investigated the effects of aficamten on cardiac muscle structure, biochemical activity, and contractile function. Aficamten does not structurally sequester myosin heads along the thick filament. It inhibits ATPase activity by decreasing myosin ATPase cycling kinetics, with the emergence of a super slow biochemical nucleotide turnover. This results in decreased force and calcium sensitivity without altering cross-bridge cycling. Our myofibril mechanical assay showed inhibition of force with accelerated relaxation. In engineered heart tissues, while mavacamten and aficamten inhibit cardiac twitch forces, mavacamten reduces the activation kinetics while both accelerate relaxation.

Authors

Institutions

Publication Details

Journal
JACC Basic to Translational Science
Published
2025-12-19
DOI
https://doi.org/10.1016/j.jacbts.2025.101449
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myosin Modulator Aficamten Inhibits Force by Altering Myosin’s Biochemical Activity Without Changing Thick Filament Structure

Bertrand C.W. Tanner, Max Mahoney-Schaefer, Kyrah L. Turner, Thomas C. Irving et al.
JACC Basic to Translational Science
Cardiomyopathy and Myosin Studies
article

Myosin Modulator Aficamten Inhibits Force by Altering Myosin’s Biochemical Activity Without Changing Thick Filament Structure

Bertrand C.W. Tanner, Max Mahoney-Schaefer, Kyrah L. Turner, Thomas C. Irving, Christian Mandrycky, Weikang Ma, Jing Zhao, Farid Moussavi‐Harami, Anthony Asencio, Kristina B. Kooiker, Timothy S. McMillen, Galina Flint, Neil M. Kad, Michael Regnier, Matvey Pilagov, Saffie Mohran, Ateeqa Naim, Siyao Jiang
article en

Abstract

We investigated the effects of aficamten on cardiac muscle structure, biochemical activity, and contractile function. Aficamten does not structurally sequester myosin heads along the thick filament. It inhibits ATPase activity by decreasing myosin ATPase cycling kinetics, with the emergence of a super slow biochemical nucleotide turnover. This results in decreased force and calcium sensitivity without altering cross-bridge cycling. Our myofibril mechanical assay showed inhibition of force with accelerated relaxation. In engineered heart tissues, while mavacamten and aficamten inhibit cardiac twitch forces, mavacamten reduces the activation kinetics while both accelerate relaxation.

JACC Basic to Translational ScienceVol. 11(1)
Illinois Institute of Technology (US), Dalian Medical University (CN), University of Washington (US), University of Kent (GB), University of Washington Applied Physics Laboratory (US)
Openalex Percentile: Top 42%
Cardiomyopathy and Myosin Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.